Department of psychiatry, NU Health Care Hospital, Trollhättan, Sweden; Department of psychology, Karlstad University, Karlstad, Sweden.
Department of psychology, Karlstad University, Karlstad, Sweden.
Schizophr Res. 2018 May;195:103-109. doi: 10.1016/j.schres.2017.09.007. Epub 2017 Sep 9.
A decade has passed since the standardized remission criteria of schizophrenia spectrum disorders-the Andreasen Criteria-were defined. Over 2000 studies have been published, but only a few describe symptomatic remission over time. In this prospective study we followed patients for 3 and 5years, respectively. The aim was to investigate how different symptoms affect the occurrence of remission and how the remission cut-off level affects remission sustainability. The participants were patients diagnosed with schizophrenia spectrum disorders (DSM-IV). First, the importance of each core symptom for remission was examined using the Positive and Negative Syndrome Scale (n=274). Second, we investigated which items affect patients to either go in and out of remission or never achieve remission (n=154). Third, we investigated how the sustainability of remission is affected by a cut-off set to 2 (minimal) and 3 (mild) points, respectively (n=154). All core symptoms affected the occurence of remission, to a higher or lesser extent. Delusions and Hallucinatory behavior contributed the strongest to fluctuation between remission and non-remission, while the contribution of Mannerism and posturing was very marginal. Negative symptoms were enhanced when remission was never achieved. Moreover, the study found that remission duration was significantly longer for the cut-off score 2 rather than 3. The study shows that, over time, remission criteria discriminate between being stable, unstable, or never in remission. Patients with only a minimal occurrence of symptom intensity exhibit a significantly longer remission duration compared to patients with mild symptom intensity, indicating that the treatment goal should be minimal symptom intensity.
自精神分裂症谱系障碍的标准化缓解标准(Andreasen 标准)定义以来,已经过去了十年。已经发表了超过 2000 项研究,但只有少数研究描述了随时间的症状缓解。在这项前瞻性研究中,我们分别随访了患者 3 年和 5 年。目的是调查不同症状如何影响缓解的发生,以及缓解截止水平如何影响缓解的可持续性。参与者被诊断为精神分裂症谱系障碍(DSM-IV)。首先,使用阳性和阴性症状量表(n=274)检查每个核心症状对缓解的重要性。其次,我们调查了哪些项目会影响患者是否进入或退出缓解期,或者从未达到缓解期(n=154)。第三,我们研究了缓解的可持续性如何受到分别设定为 2(最小)和 3(轻度)点的截止值的影响(n=154)。所有核心症状都或多或少地影响了缓解的发生。妄想和幻觉行为对缓解和非缓解之间的波动贡献最大,而举止和姿势的贡献则非常微不足道。当从未达到缓解时,阴性症状会加重。此外,该研究发现,缓解截止评分 2 比 3 时,缓解持续时间明显更长。该研究表明,随着时间的推移,缓解标准可以区分稳定、不稳定或从未缓解。仅出现最小程度症状强度的患者缓解持续时间明显更长,与出现轻度症状强度的患者相比,这表明治疗目标应该是最小程度的症状强度。